acetylcarnitine has been researched along with Amentia in 23 studies
Acetylcarnitine: An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The acute effects of intravenously administered L-acetylcarnitine (LAC) were evaluated with single-photon emission computed tomography (SPECT) and 99mTc-hexamethylpropyleneamine oxime in 30 demented patients (21 with a clinical diagnosis of Alzheimer's dementia and 9 with mixed-type dementia)." | 7.67 | Single-photon emission computed tomography studies with 99mTc-hexamethylpropyleneamine oxime in dementia: effects of acute administration of L-acetylcarnitine. ( Battistin, L; Borsato, N; Calvani, M; Da Col, C; Dam, M; Ferlin, G; Perlotto, N; Pizzolato, G; Saitta, B, 1989) |
| "Adults of both genders without dementia consumed a nutriceutical formulation ("NF," consisting of folic acid, B12, Vitamin E, S-adenosylmethionine, N-acetyl cysteine and Acetyl-L-carnitine), previously shown to improve cognitive performance in Alzheimer's disease, or placebo." | 5.14 | A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia. ( Chan, A; Kotyla, E; Lepore, A; Remington, R; Shea, TB; Zemianek, J, 2010) |
| "The trials were identified from a search of the Specialized Register of the Cochrane Dementia and Cognitive Improvement Group on 8 January 2003 using the terms acetyl-l-carnitine, l-carnitine acetyl ester, acetylcarnitine." | 4.82 | Acetyl-L-carnitine for dementia. ( Hudson, S; Tabet, N, 2003) |
| "The acute effects of intravenously administered L-acetylcarnitine (LAC) were evaluated with single-photon emission computed tomography (SPECT) and 99mTc-hexamethylpropyleneamine oxime in 30 demented patients (21 with a clinical diagnosis of Alzheimer's dementia and 9 with mixed-type dementia)." | 3.67 | Single-photon emission computed tomography studies with 99mTc-hexamethylpropyleneamine oxime in dementia: effects of acute administration of L-acetylcarnitine. ( Battistin, L; Borsato, N; Calvani, M; Da Col, C; Dam, M; Ferlin, G; Perlotto, N; Pizzolato, G; Saitta, B, 1989) |
| "Dementia is a common mental health problem affecting 5% of those over 65." | 2.42 | Acetyl-L-carnitine for dementia. ( Hudson, S; Tabet, N, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (17.39) | 18.7374 |
| 1990's | 15 (65.22) | 18.2507 |
| 2000's | 1 (4.35) | 29.6817 |
| 2010's | 2 (8.70) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Pennisi, M | 1 |
| Lanza, G | 1 |
| Cantone, M | 1 |
| D'Amico, E | 1 |
| Fisicaro, F | 1 |
| Puglisi, V | 1 |
| Vinciguerra, L | 1 |
| Bella, R | 1 |
| Vicari, E | 1 |
| Malaguarnera, G | 1 |
| Ferrari, F | 1 |
| Gorini, A | 1 |
| Villa, RF | 1 |
| Chan, A | 1 |
| Remington, R | 1 |
| Kotyla, E | 1 |
| Lepore, A | 1 |
| Zemianek, J | 1 |
| Shea, TB | 1 |
| Hudson, S | 1 |
| Tabet, N | 1 |
| Acierno, G | 1 |
| Ganesan, R | 1 |
| Standish, T | 1 |
| Molloy, DW | 1 |
| Darzins, P | 1 |
| Orange, JB | 1 |
| Kidd, PM | 1 |
| Lino, A | 1 |
| Boccia, MM | 1 |
| Rusconi, AC | 1 |
| Bellomonte, L | 1 |
| Cocuroccia, B | 1 |
| Herrmann, WM | 1 |
| Stephan, K | 1 |
| Recchia, G | 2 |
| Zerbini, O | 1 |
| Fabbri, L | 1 |
| Neri, M | 1 |
| Cortelloni, C | 1 |
| De Vreese, L | 1 |
| Roncolato, M | 1 |
| Meneghetti, M | 1 |
| Bamfi, F | 1 |
| Girelli, M | 1 |
| Cipolli, C | 1 |
| Chiari, G | 1 |
| Genazzani, E | 1 |
| Goety, CG | 1 |
| Tanner, CM | 1 |
| Cohen, JA | 1 |
| Thelen, JA | 1 |
| Carroll, VS | 1 |
| Klawans, HL | 1 |
| Fariello, RG | 1 |
| Passeri, M | 2 |
| Cucinotta, D | 2 |
| Bonati, PA | 2 |
| Iannuccelli, M | 3 |
| Parnetti, L | 1 |
| Senin, U | 1 |
| Garzya, G | 1 |
| Corallo, D | 1 |
| Fiore, A | 1 |
| Lecciso, G | 1 |
| Petrelli, G | 1 |
| Zotti, C | 1 |
| Sinforiani, E | 1 |
| Mauri, M | 1 |
| Costa, A | 1 |
| Merlo, P | 1 |
| Bono, G | 1 |
| Nappi, G | 1 |
| Battistin, L | 1 |
| Pizzolato, G | 1 |
| Dam, M | 1 |
| Da Col, C | 1 |
| Perlotto, N | 1 |
| Saitta, B | 1 |
| Borsato, N | 1 |
| Calvani, M | 1 |
| Ferlin, G | 1 |
| Ciotti, G | 1 |
| Nolfe, G | 1 |
| Davoli, D | 1 |
| Marchesi, M | 1 |
| Bertolotti, S | 1 |
| Bellesia, G | 1 |
| Pioli, G | 1 |
| Iori, E | 1 |
5 reviews available for acetylcarnitine and Amentia
| Article | Year |
|---|---|
Acetyl-L-Carnitine in Dementia and Other Cognitive Disorders: A Critical Update.
Topics: Acetylcarnitine; Brain; Cognition; Cognition Disorders; Dementia; Humans; Liver; Nootropic Agents; T | 2020 |
Acetyl-L-carnitine for dementia.
Topics: Acetylcarnitine; Aged; Alzheimer Disease; Dementia; Humans; Nootropic Agents; Randomized Controlled | 2003 |
New treatments for dementia. Myth, magic, and science.
Topics: Acetylcarnitine; Adult; Aged; Aged, 80 and over; Attitude to Death; Attitude to Health; Canada; Cult | 1994 |
A review of nutrients and botanicals in the integrative management of cognitive dysfunction.
Topics: Acetylcarnitine; Cognition Disorders; Complementary Therapies; Dementia; Ginkgo biloba; Humans; Noot | 1999 |
[Pharmacologic treatment of senile mental deterioration].
Topics: Acetylcarnitine; Cytidine Diphosphate Choline; Dementia; Humans; Neuropeptides; Parasympathomimetics | 1987 |
14 trials available for acetylcarnitine and Amentia
| Article | Year |
|---|---|
A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia.
Topics: Acetylcarnitine; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Dementia; Dietary Suppleme | 2010 |
[The use of 1-acetylcarnitine in (presenile and senile) Alzheimer's disease. Preliminary results].
Topics: Acetylcarnitine; Aged; Alzheimer Disease; Carnitine; Clinical Trials as Topic; Dementia; Double-Blin | 1983 |
[Psycho-functional changes in attention and learning under the action of L-acetylcarnitine in 17 young subjects. A pilot study of its use in mental deterioration].
Topics: Acetylcarnitine; Adult; Age Factors; Analysis of Variance; Attention; Dementia; Female; Humans; Lear | 1992 |
Efficacy and clinical relevance of cognition enhancers.
Topics: Acetylcarnitine; Clinical Trials as Topic; Cognition; Cognition Disorders; Dementia; Humans; Nimodip | 1991 |
[Aging of the population: the 2d demographic revolution].
Topics: Acetylcarnitine; Aged; Aged, 80 and over; Carnitine; Clinical Trials as Topic; Dementia; Demography; | 1990 |
[Clinical development of a drug for brain aging. Current limitations and future prospects].
Topics: Acetylcarnitine; Aged; Carnitine; Clinical Trials as Topic; Dementia; Diagnosis, Differential; Human | 1990 |
[Methodology of a clinical controlled study of L-acetylcarnitine].
Topics: Acetylcarnitine; Aged; Carnitine; Clinical Trials as Topic; Dementia; Humans; Middle Aged; Multicent | 1990 |
[Center monitoring and management of data bases].
Topics: Acetylcarnitine; Carnitine; Clinical Trials as Topic; Database Management Systems; Dementia; Humans; | 1990 |
[Effects of L-acetylcarnitine on mental deterioration in the aged: initial results].
Topics: Acetylcarnitine; Aged; Analysis of Variance; Behavior; Carnitine; Clinical Trials as Topic; Cognitio | 1990 |
[A controlled clinical study on the efficacy of L-acetylcarnitine in the treatment of mild-to-moderate mental deterioration in the aged. Conclusions].
Topics: Acetylcarnitine; Aged; Carnitine; Clinical Trials as Topic; Dementia; Humans; Middle Aged; Multicent | 1990 |
L-acetyl-carnitine in Huntington's disease: double-blind placebo controlled crossover study of drug effects on movement disorder and dementia.
Topics: Acetylcarnitine; Adult; Aged; Carnitine; Dementia; Double-Blind Method; Female; Humans; Huntington D | 1990 |
Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
Topics: Acetylcarnitine; Aged; Carnitine; Cognition; Dementia; Double-Blind Method; Female; Humans; Male; Ra | 1990 |
Evaluation of the effects of L-acetylcarnitine on senile patients suffering from depression.
Topics: Acetylcarnitine; Aged; Aged, 80 and over; Carnitine; Clinical Trials as Topic; Dementia; Depressive | 1990 |
Mental impairment in aging: selection of patients, methods of evaluation and therapeutic possibilities of acetyl-L-carnitine.
Topics: Acetylcarnitine; Aged; Aged, 80 and over; Analysis of Variance; Carnitine; Dementia; Female; Humans; | 1988 |
4 other studies available for acetylcarnitine and Amentia
| Article | Year |
|---|---|
Functional proteomics of synaptic plasma membrane ATP-ases of rat hippocampus: effect of l-acetylcarnitine and relationships with Dementia and Depression pathophysiology.
Topics: Acetylcarnitine; Acetylcholinesterase; Adenosine Triphosphatases; Animals; Dementia; Depression; Fem | 2015 |
[Methodological premises of statistical analysis of the data].
Topics: Acetylcarnitine; Age Factors; Aged; Analysis of Variance; Carnitine; Data Interpretation, Statistica | 1990 |
Neuropsychological changes in demented patients treated with acetyl-L-carnitine.
Topics: Acetylcarnitine; Aged; Brain Ischemia; Carnitine; Dementia; Female; Humans; Male; Middle Aged; Pirac | 1990 |
Single-photon emission computed tomography studies with 99mTc-hexamethylpropyleneamine oxime in dementia: effects of acute administration of L-acetylcarnitine.
Topics: Acetylcarnitine; Aged; Alzheimer Disease; Carnitine; Dementia; Female; Humans; Injections, Intraveno | 1989 |